NG Industries Fair Value
NG Industries (NGIND) average fair value is ₹187.86 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹117.45 (+59.95%), fair value range ₹113.33–₹380.38. Browse NGIND annual financials for revenue, profit, balance sheet and cash flow data.
Fair Value Analysis Export
NGIND Fair Value vs Current Price — Valuation Summary
NGIND average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). Read NGIND dividend growth for the complete payout history and dividend yield track record.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
NGIND Fair Value Analysis — Data Sources & Coverage
NG Industries financial data sources, valuation methods applied and sector benchmarks used. For live price and a broader fundamental view, visit NGIND share price.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
NGIND vs Healthcare Services Sector Peers — P/E, P/B & Market Cap
NG Industries P/E ratio, P/B ratio and market capitalisation vs Healthcare Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Apollo Hospitals | APOLLOHOSP | 57.92 | 13.27 | ₹128,608 |
| Dr. Agarwal's Health Care | AGARWALEYE | 86.82 | 7.91 | ₹15,914 |
| Broach Lifecare Hospital | BROACH | - | - | ₹9 |
| Gujarat Kidney and Super… | GKSL | 81.75 | 5.41 | ₹1,332 |
| Jupiter Life Line Hospit… | JLHL | 44.49 | 5.79 | ₹8,320 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.